PharmEasy buys majority stake in healthcare supply chain start-up Aknamed

API's subsidiary PharmEasy, which is planning an IPO, will acquire 975,937 equity share in the company

money, cash, investment, stocks, tax, funds, investors, investment, shares, lenders, lending, loans, funding
Premium

Shivani Shinde Mumbai
API Holdings, the parent company of PharmEasy, has acquired a majority stake in healthcare supply chain start-up Aknamed for an initial investment of Rs 308 crore. Sources said PharmEasy will complete the acquisition in a few months, with the total deal size being about Rs 1,000 crore. This will be the third acquisition by PharmEasy this year.
 
PharmEasy, which is planning an IPO, has acquired 975,937 equity shares in the company, said a regulatory filing. The founders of Aknamed will continue to be with the company and join API Holdings, sources said.
 
There had been reports that PharmEasy was looking to acquire Akna Medical Pvt Ltd, the parent company of Aknamed.
 
“API Holdings have acquired the controlling

First Published: Sep 14 2021 | 3:04 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com